Study of the antitumor effects of photodynamic therapy (PDT) and compounds inducing endoplasmic reticulum stress.
Project leader: prof. Jakub Gołąb, MD, PhD (Medical University of Warsaw).
Project partners: KU Leuven (Belgium), University College Dublin (Ireland).
Application of anti-CD20 monoclonal antibodies in cancer treatment.
Project leader: Magdalena Winiarska, PhD (Medical University of Warsaw).
Project partner: Universite de la Mediterranée (Marseille, France).
Study and identification of potential target moleculesand efficiency markers in the treatment of chronic myeloid leukaemia.
Project leader: Tomasz Stokłosa, MD, PhD (Medical University of Warsaw).
Project partner: University Hospital of Ulm (Germany).
Vascular mechanisms in metastasis.
Project leader: prof. Zbigniew Gaciong, MD, PhD (Medical University of Warsaw).
Project partner: Karolinska Institutet (Stockholm, Sweden).
Study of metalloprotease inhibitors in prostate cancer.
Project leader: Paweł Włodarski, MD, PhD (Medical University of Warsaw).
Project partners: Radboud University Medical Center Nijmegen (Netherlands), Saarland University (Germany).
Study of the role of microRNA sequence variance in theefficiency of cancer treatment.
Project leader: Krystian Jażdżewski, MD, PhD (Medical University of Warsaw).
Project partners: University of Ferrara (Italy), Leeds Institute for Molecular Medicine, University of Leeds (UK).
Study of circulating tumour cells in the colorectal cancer diagnostics.
Project leader: Piotr Religa, MD, PhD (Medical University of Warsaw).
Project partner: Karolinska Institutet (Stockholm, Sweden).
Molecular and genomic study of carcinogenesis related to infections with human papilloma virus.
Project leader: prof. Sławomir Majewski, MD, PhD (Medical University of Warsaw).
Project partner: University of Cologne (Germany).
Study of proteasome inhibitors and mechanisms of protein folding as potential targets in personalised cancer therapy.
Project leader: Dominika Nowis, MD, PhD (Medical University of Warsaw).
Project partner: University of Verona (Italy).
Role of peroxiredoxin 1 in human malignancies
Project leader: Radosław Zagożdżon, MD, PhD (Medical University of Warsaw).
Project partners: University College Dublin; Beaumont Hospital.